IDenta Corp. (IDTA)
USD 0.45
(0.0%)
USD 0.45
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 524.85 Thousand USD | 16.28% |
| 2022 | 451.37 Thousand USD | 174.43% |
| 2021 | 164.47 Thousand USD | 386.11% |
| 2020 | -57.48 Thousand USD | -117.9% |
| 2019 | 321.1 Thousand USD | 21.09% |
| 2018 | 265.17 Thousand USD | -56.76% |
| 2017 | 613.31 Thousand USD | 1.15% |
| 2016 | 606.35 Thousand USD | 290.51% |
| 2015 | 155.27 Thousand USD | -4.17% |
| 2014 | 162.02 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 249.71 Thousand USD | -40.02% |
| 2024 Q1 | 416.36 Thousand USD | -20.67% |
| 2023 Q4 | 524.85 Thousand USD | 584.35% |
| 2023 Q1 | 493.41 Thousand USD | 9.31% |
| 2023 Q2 | 489.25 Thousand USD | -0.84% |
| 2023 FY | 524.85 Thousand USD | 16.28% |
| 2023 Q3 | 76.69 Thousand USD | -84.32% |
| 2022 Q3 | 210.43 Thousand USD | 1.92% |
| 2022 FY | 451.37 Thousand USD | 174.43% |
| 2022 Q1 | 124.09 Thousand USD | -24.55% |
| 2022 Q2 | 206.47 Thousand USD | 66.38% |
| 2022 Q4 | 451.37 Thousand USD | 114.49% |
| 2021 Q1 | 96.45 Thousand USD | 267.77% |
| 2021 FY | 164.47 Thousand USD | 386.11% |
| 2021 Q4 | 164.47 Thousand USD | 10.92% |
| 2021 Q3 | 148.28 Thousand USD | 47.49% |
| 2021 Q2 | 100.53 Thousand USD | 4.24% |
| 2020 Q2 | -103.49 Thousand USD | -126.64% |
| 2020 Q1 | 388.56 Thousand USD | 21.01% |
| 2020 Q3 | -109.81 Thousand USD | -6.1% |
| 2020 FY | -57.48 Thousand USD | -117.9% |
| 2020 Q4 | -57.48 Thousand USD | 47.65% |
| 2019 Q4 | 321.1 Thousand USD | 116.18% |
| 2019 Q1 | 308.16 Thousand USD | 16.21% |
| 2019 Q2 | 226.28 Thousand USD | -26.57% |
| 2019 FY | 321.1 Thousand USD | 21.09% |
| 2019 Q3 | 148.53 Thousand USD | -34.36% |
| 2018 Q2 | 469.5 Thousand USD | 200.53% |
| 2018 FY | 265.17 Thousand USD | -56.76% |
| 2018 Q4 | 265.17 Thousand USD | -28.36% |
| 2018 Q3 | 370.17 Thousand USD | -21.16% |
| 2018 Q1 | 156.22 Thousand USD | -61.07% |
| 2017 FY | 613.31 Thousand USD | 1.15% |
| 2017 Q4 | 401.26 Thousand USD | 0.0% |
| 2016 FY | 606.35 Thousand USD | 290.51% |
| 2015 FY | 155.27 Thousand USD | -4.17% |
| 2014 FY | 162.02 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 76.208% |
| Arrayit Corporation | 1.05 Million USD | 50.278% |
| Atlantic International Corp. | 236.49 Thousand USD | -121.928% |
| Biocept, Inc. | -788 Thousand USD | 166.606% |
| Bioqual, Inc. | -12 Million USD | 104.371% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -2208.158% |
| DermTech, Inc. | 17.65 Million USD | 97.027% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.092% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 107.115% |
| iMD Companies, Inc. | 1.11 Million USD | 52.967% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 93.178% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 2047.358% |
| InVitro International | -313.14 Thousand USD | 267.608% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 66.483% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 73711.781% |
| Medical Imaging Corp. | 3.79 Million USD | 86.155% |
| NovelStem International Corp. | 3.52 Million USD | 85.096% |
| Optigenex Inc. | 8.93 Million USD | 94.125% |
| PharmChem, Inc. | -1.49 Million USD | 135.121% |
| Proteome Sciences plc | 14.57 Million USD | 96.399% |
| Response Genetics, Inc | -13.08 Million USD | 104.011% |
| Rennova Health, Inc. | 14.82 Million USD | 96.461% |
| RushNet, Inc. | 4.8 Million USD | 89.068% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -287.09% |
| Stella Diagnostics Inc. | 6.19 Million USD | 91.525% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 70.587% |
| Todos Medical Ltd. | 38.31 Million USD | 98.63% |